南微医学收盘上涨3.73%，滚动市盈率29.70倍，总市值180.03亿元

Group 1 - The core viewpoint of the articles highlights that Nanwei Medical's stock price closed at 95.84 yuan, with a 3.73% increase, and a rolling PE ratio of 29.70, marking a new low in 391 days, with a total market capitalization of 18.003 billion yuan [1] - The average PE ratio for the medical device industry is 57.51, with a median of 41.25, placing Nanwei Medical at the 57th position in the industry ranking [1] - As of the 2025 semi-annual report, 25 institutions hold shares in Nanwei Medical, including 18 funds, 3 social security funds, 3 others, and 1 brokerage, with a total holding of 106.2244 million shares valued at 7.175 billion yuan [1] Group 2 - Nanwei Medical specializes in the research, manufacturing, and sales of minimally invasive medical devices, with key products including endoscopic diagnostic devices, microwave/radiofrequency ablation equipment and consumables, and disposable endoscopes [1] - The latest performance report for the first half of 2025 shows that the company achieved an operating income of 1.565 billion yuan, a year-on-year increase of 17.36%, and a net profit of 363 million yuan, also a year-on-year increase of 17.04%, with a gross profit margin of 64.89% [1] - The TTM PE ratio for Nanwei Medical is 29.70, while the static PE is 32.54, and the price-to-book ratio is 4.47 [2]